Drug Type Polysaccharide |
Synonyms DOP |
Target |
Action inhibitors |
Mechanism CTNNB inhibitors(Beta catenins inhibitors), TGF-β1 inhibitors(Transforming growth factor beta 1 inhibitors), Wnt inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Fibrosis, Liver | Preclinical | China | 20 Oct 2025 | |
| Heart Injuries | Preclinical | China | 01 May 2025 |





